Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 13.13 billion as of April 24, 2025. Its market cap has decreased by -11.84% in one year.

Market Cap

13.13B

Enterprise Value

15.19B

Revenue

5.38B

Ranking

n/a

PE Ratio

18.29

Stock Price

31.25

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 13.13B, an increase of 2,150.78%. That is a compound annual growth rate of 17.83%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2025	13.13B	-9.42%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	6.81B	20.87%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	160.86B
Caliway Biopharmaceuticals	93.07B
Bora Pharmaceuticals Co., LTD.	67.36B
Lotus Pharmaceutical	54.79B
Polaris Group	28.88B
Oneness Biotech	27.68B
Lumosa Therapeutics	25.50B
Pegavision	25.35B

Market Cap Rankings